Assessing quality of life in patients with bronchiectasis using oscillating PEP devices
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
This study is testing if using an oscillating PEP device can improve the daily lives and well-being of children and adults with bronchiectasis who aren't currently using one.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 8 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT06820983 on ClinicalTrials.gov |
What this trial studies
This study evaluates the quality of life and adherence to treatment in children and adults with bronchiectasis who are not currently using oscillating positive expiratory pressure (PEP) devices. Participants will complete various questionnaires to assess their quality of life before and after the introduction of the oscillating PEP device. The goal is to determine how this device impacts their daily lives and overall well-being. The study will include clinically stable patients who are regularly followed up in consultations.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 8 and older and adults with stable bronchiectasis who are not currently using oscillating PEP devices.
Not a fit: Patients under 8 years of age, those currently using an oscillating PEP device, or those experiencing acute exacerbations of bronchiectasis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for patients with bronchiectasis by demonstrating the benefits of using oscillating PEP devices.
How similar studies have performed: While this approach is relatively novel, previous studies have shown positive outcomes with similar interventions in improving quality of life for patients with respiratory conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP. The study population will be clinically stable and will be seen in follow-up consultations. Exclusion Criteria: * Children under 8 years of age. * Patients who use an OPEP * Patients in the acute exacerbation phase of their DDB * Patients who are not under regular consultation * Patients with severe, uncontrolled co-morbidities * Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol * Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study
Where this trial is running
Amiens
- CHU Amiens-Picardie — Amiens, France (Recruiting)
Study contacts
- Study coordinator: Thomas PINTO, MD
- Email: pinto.thomas@chu-amiens.fr
- Phone: 33+3 22 08 80 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.